Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 286

Similar articles for PubMed (Select 23441068)

1.

One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.

Shiratori Y, Brugaletta S, Alvarez-Contreras L, Azpeitia Y, Ospino N, Gaido S, Delahanty A, Santos A, Martin-Yuste V, Masotti M, Serruys PW, Windecker S, Sabaté M.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E428-36. doi: 10.1002/ccd.24897. Epub 2013 Mar 25.

PMID:
23441068
2.

Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer Coated Stent Implantation.

Konishi A, Shinke T, Otake H, Takaya T, Osue T, Kinutani H, Kuroda M, Takahashi H, Terashita D, Shite J, Hirata KI.

Can J Cardiol. 2015 Mar 5. pii: S0828-282X(15)00176-2. doi: 10.1016/j.cjca.2015.02.036. [Epub ahead of print]

PMID:
26117623
3.

The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.

Taniwaki M, Windecker S, Zaugg S, Stefanini GG, Baumgartner S, Zanchin T, Wenaweser P, Meier B, Jüni P, Räber L.

Eur Heart J. 2015 Jun 3. pii: ehv227. [Epub ahead of print]

PMID:
26040806
4.
5.

A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.

Kochman J, Tomaniak M, Kołtowski Ł, Jąkała J, Proniewska K, Legutko J, Roleder T, Pietrasik A, Rdzanek A, Kochman W, Brugaletta S, Kaluza GL.

Catheter Cardiovasc Interv. 2015 May 25. doi: 10.1002/ccd.26006. [Epub ahead of print]

PMID:
26015294
6.

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China.

Chen JH, Wu YZ, Shen L, Zhang F, Yao ZF, Yin JS, Ji M, Wang QB, Ge L, Qian JY, Hu X, Xie J, Ge JB.

Chin Med J (Engl). 2015 5th May;128(9):1275-1276. doi: 10.4103/0366-6999.156155. No abstract available.

7.

COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.

Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T.

EuroIntervention. 2015 May 7;11(1). pii: 20141026-04. doi: 10.4244/EIJY15M05_02. [Epub ahead of print]

8.

1-year follow-up optical coherence tomography of a "hybrid" neocarina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent.

Naganuma T, Panoulas VF, Latib A, Kawamoto H, Sato K, Miyazaki T, Colombo A.

JACC Cardiovasc Interv. 2015 May;8(6):e101-3. doi: 10.1016/j.jcin.2015.01.025. Epub 2015 Apr 22. No abstract available.

PMID:
25912406
9.

Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.

Burzotta F, Brancati MF, Trani C, Pirozzolo G, De Maria G, Leone AM, Niccoli G, Porto I, Prati F, Crea F.

Heart Vessels. 2015 Apr 12. [Epub ahead of print]

PMID:
25863804
10.

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Farooq V, Mamas MA, Fraser DG, El-Omar M, Clarke B, Fath-Ordoubadi F.

EuroIntervention. 2015 Mar 22;10(11):e1. doi: 10.4244/EIJV10I11A224. No abstract available.

11.

Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.

Karanasos A, Garcia-Garcia HM, van Geuns RJ, Regar E.

JACC Cardiovasc Interv. 2015 Mar;8(3):e53-4. doi: 10.1016/j.jcin.2014.10.020. No abstract available.

PMID:
25790767
12.

Vascular response after Zilver PTX stent implantation for superficial femoral artery lesions: serial optical coherence tomography findings at 6 and 12 months.

Tomoi Y, Kuramitsu S, Soga Y, Aihara H, Ando K, Nobuyoshi M.

J Endovasc Ther. 2015 Feb;22(1):41-7. doi: 10.1177/1526602814566577.

PMID:
25775679
13.

An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).

Ormiston JA, Webber B, Ubod B, Darremont O, Webster MW.

EuroIntervention. 2015 May 19;11(1):60-7. doi: 10.4244/EIJY15M02_03.

14.

Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study.

Prati F, Kodama T, Romagnoli E, Gatto L, Di Vito L, Ramazzotti V, Chisari A, Marco V, Cremonesi A, Parodi G, Albertucci M, Alfonso F.

Am Heart J. 2015 Feb;169(2):249-56. doi: 10.1016/j.ahj.2014.11.012. Epub 2014 Nov 20.

PMID:
25641534
15.

Optical coherence tomographic evaluation of the effect of cigarette smoking on vascular healing after sirolimus-eluting stent implantation.

Gao L, Park SJ, Jang Y, Lee S, Tian J, Minami Y, Jia H, Ong D, Soeda T, Vergallo R, Lee H, Yu B, Uemura S, Jang IK.

Am J Cardiol. 2015 Mar 15;115(6):751-7. doi: 10.1016/j.amjcard.2014.12.038. Epub 2015 Jan 6.

PMID:
25620038
16.

Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.

Oda T, Okamura T, Yamada J, Miyagi N, Uehara H, Nao T, Tateishi H, Maeda T, Nakamura T, Shiraishi K, Nakashima T, Nishimura S, Miura T, Matsuzaki M, Yano M.

Heart Vessels. 2015 Jan 23. [Epub ahead of print]

PMID:
25614415
17.

Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.

Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Circ Cardiovasc Interv. 2015 Feb;8(2):e001878. doi: 10.1161/CIRCINTERVENTIONS.114.001878.

PMID:
25613674
18.

Hypersensitivity reaction in the US Food and Drug Administration-approved second-generation drug-eluting stents: histopathological assessment with ex vivo optical coherence tomography.

Otsuka F, Yahagi K, Ladich E, Kutys R, Alexander R, Fowler D, Virmani R, Joner M.

Circulation. 2015 Jan 20;131(3):322-4. doi: 10.1161/CIRCULATIONAHA.114.012658. No abstract available.

PMID:
25601953
19.

Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.

Biscaglia S, Secco GG, Tumscitz C, Di Mario C, Campo G.

Int J Cardiol. 2015 Mar 1;182:1-3. doi: 10.1016/j.ijcard.2014.12.103. Epub 2014 Dec 28. No abstract available.

PMID:
25590956
20.

Optical coherence tomography surveillance following drug-eluting stent implantation.

Koppara T, Virmani R, Joner M.

Minerva Cardioangiol. 2015 Feb;63(1):59-74. Epub 2015 Jan 8.

PMID:
25566936
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk